Our Products in Europe
All of our products are prescription-only medicines (POM). If more information is required, please refer to the local SPC or PIL.

ABILIFY® (aripiprazole)

ABILIFY contains the active substance aripiprazole. It is available in different forms (tablets, oral solution and a solution for injection).

ABILIFY MAINTENA® (aripiprazole)

ABILIFY MAINTENA contains the active substance aripiprazole. It is available as a powder and solvent to be made into a suspension for injection.

SAMSCA® (tolvaptan)

SAMSCA contains the active substance tolvaptan. It is available as a tablet.

JINARC®▼ (tolvaptan)

JINARC contains the active ingredient tolvaptan and it is available as a tablet.

SPRYCEL® (dasatinib)

SPRYCEL contains the active substance dasatinib and is available as tablets of various strengths. The medicine can only be obtained with a prescription. The Marketing Authorisation Holder of the drug is Bristol-Myers Squibb Pharma EEIG.

Pletal® (cilostazol)

Pletal contains the active substance cilostazol. It is available as a tablet.

Adacolumn® - Medical device

For more information about Otsuka’s global portfolio, please visit our global website. For information on products that are currently in the pipeline, please visit the Otsuka Holdings Co., Ltd. website.